首页> 美国卫生研究院文献>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America >Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group
【2h】

Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group

机译:推进诊断以解决抗菌素耐药性:抗菌素耐药性领导小组诊断与设备委员会

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diagnostics are a cornerstone of the practice of infectious diseases. However, various limitations frequently lead to unmet clinical needs. In most other domains, diagnostics focus on narrowly defined questions, provide readily interpretable answers, and use true gold standards for development. In contrast, infectious diseases diagnostics must contend with scores of potential pathogens, dozens of clinical syndromes, emerging pathogens, rapid evolution of existing pathogens and their associated resistance mechanisms, and the absence of gold standards in many situations. In spite of these challenges, the importance and value of diagnostics cannot be underestimated. Therefore, the Antibacterial Resistance Leadership Group has identified diagnostics as 1 of 4 major areas of emphasis. Herein, we provide an overview of that development, highlighting several examples where innovation in study design, content, and execution is advancing the field of infectious diseases diagnostics.
机译:诊断是传染病实践的基石。然而,各种限制常常导致未满足的临床需求。在大多数其他领域,诊断程序只关注定义狭窄的问题,提供易于理解的答案,并使用真正的金标准进行开发。相反,传染病诊断必须应对许多潜在的病原体,数十种临床综合征,新出现的病原体,现有病原体的快速进化及其相关的耐药机制,以及在许多情况下缺乏金标准。尽管存在这些挑战,但不能低估诊断的重要性和价值。因此,抗菌素耐药性领导小组已将诊断方法确定为4个主要重点领域之一。在此,我们概述了这一发展,重点介绍了研究设计,内容和执行方面的创新正在推动传染病诊断领域发展的几个例子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号